Back to News
Market Impact: 0.05
Helus Pharma to Participate at the H.C. Wainwright 28th Annual Global Investment Conference in New York
Source: globenewswire.com
Management & Governance
CEO Michael Halstead will participate in a fireside chat on September 14, 2026, at 9:00 a.m. EDT. The announcement provides no financial results, operational update, or guidance change.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.00
More News
- How Pepsi fell behind in the cola wars—and then lost KFC
- ‘We like to be first to be second’: How True Religion’s CEO is rebuilding the denim brand for Gen Z and millennials
- Thousands of Israelis rally against Netanyahu gov’t days before election
- Jamie Dimon poached Warren Buffett’s protégé to run a $10 billion fund—he says Buffett’s response was ‘at least he’s going to you’
- Serbia votes in election pitting longtime leader against student movement
- ‘Nobody prepared them’: The ultrawealthy worry wealth will dull their heirs’ ‘drive and desire’ and so some aren’t telling them how much there is
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- AI Tools for CFA Charterholders: An Evidence Standard
- Weekly Update: Unstructured Data Search, Ask AI, and Advanced Futures Data